During the past decade, Neuro-Consil Gmbh conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Neuro-Consil Gmbh" are "Epilepsy" (1 trials), "Muscle Spasticity" (1 trials) and "Neuralgia, Postherpetic" (1 trials). Many other conditions were trialed in "Neuro-Consil Gmbh" in a lesser frequency.

Most popular intervention types in "Neuro-Consil Gmbh" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "AGN-214868" (1 trials), "AGN-214868 Placebo (Vehicle)" (1 trials), "Zonegran" (1 trials) and "tolperisone HCl" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neuro-Consil Gmbh" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Neuro-Consil Gmbh". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Neuro-Consil Gmbh, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Neuro-Consil Gmbh, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".